Investigation of seasonal frequency and pathogens in febrile neutropenia.

Fever Hematological Months Neutropenia Seasons

Journal

Memo
ISSN: 1865-5041
Titre abrégé: Memo
Pays: Austria
ID NLM: 101467972

Informations de publication

Date de publication:
2019
Historique:
received: 08 10 2018
accepted: 18 12 2018
entrez: 29 3 2020
pubmed: 1 1 2019
medline: 1 1 2019
Statut: ppublish

Résumé

In patients with hematological malignancies, febrile neutropenia (FEN) is the most frequent complication and the most important cause of mortality. Various risk factors have been identified for severe infection in neutropenic patients. However, to the best of our knowledge, it is not defined whether there is a change in the risk of febrile neutropenia according to seasons. The first aim of study was to determine the difference in frequency of febrile neutropenic episodes (FNEs) according to months and seasons. The second aim was to document isolated pathogens, as well as demographical and clinical characteristics of patients. In the study, 194 FNEs of 105 patients who have been followed with hematological malignancies between June 2013 and May 2014 were evaluated retrospectively. Although the number of FNEs increased in autumn, there was no significant difference in frequency of FNEs between months ( The frequency of FEN does not change according to months or seasons. Also, the relative proportions of different pathogens in the cause of FEN do not vary according to seasons.

Sections du résumé

BACKGROUND BACKGROUND
In patients with hematological malignancies, febrile neutropenia (FEN) is the most frequent complication and the most important cause of mortality. Various risk factors have been identified for severe infection in neutropenic patients. However, to the best of our knowledge, it is not defined whether there is a change in the risk of febrile neutropenia according to seasons. The first aim of study was to determine the difference in frequency of febrile neutropenic episodes (FNEs) according to months and seasons. The second aim was to document isolated pathogens, as well as demographical and clinical characteristics of patients.
METHODS METHODS
In the study, 194 FNEs of 105 patients who have been followed with hematological malignancies between June 2013 and May 2014 were evaluated retrospectively.
RESULTS RESULTS
Although the number of FNEs increased in autumn, there was no significant difference in frequency of FNEs between months (
CONCLUSIONS CONCLUSIONS
The frequency of FEN does not change according to months or seasons. Also, the relative proportions of different pathogens in the cause of FEN do not vary according to seasons.

Identifiants

pubmed: 32218873
doi: 10.1007/s12254-018-0468-z
pii: 468
pmc: PMC7091104
doi:

Types de publication

Journal Article

Langues

eng

Pagination

119-122

Informations de copyright

© Springer-Verlag GmbH Austria, part of Springer Nature 2019.

Déclaration de conflit d'intérêts

Conflict of interestS.K. Özdemir, U. Iltar, O. Salim, O.K. Yücel, R. Erdem, Ö. Turhan, and L. Undar declare that they have no competing interests.

Références

Clin Infect Dis. 2002 Mar 15;34(6):730-51
pubmed: 11850858
Prim Care. 1996 Dec;23(4):657-75
pubmed: 8890137
Clin Infect Dis. 2011 Feb 15;52(4):427-31
pubmed: 21205990
N Engl J Med. 1993 May 6;328(18):1323-32
pubmed: 8469254
Cancer. 2005 Mar 15;103(6):1103-13
pubmed: 15666328
Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S331-4
pubmed: 25352626
Clin Infect Dis. 1996 Oct;23(4):795-805
pubmed: 8909847
Cancer. 2006 May 15;106(10):2258-66
pubmed: 16575919
Clin Infect Dis. 2003 May 1;36(9):1103-10
pubmed: 12715303
Curr Opin Infect Dis. 2002 Aug;15(4):377-82
pubmed: 12130933
Lancet. 2003 Jan 4;361(9351):51-9
pubmed: 12517470
J Clin Oncol. 2013 Feb 20;31(6):794-810
pubmed: 23319691
Arch Intern Med. 1985 Sep;145(9):1621-9
pubmed: 3927867
Ann Intern Med. 1972 Nov;77(5):707-14
pubmed: 4628214
Crit Rev Oncol Hematol. 2014 Jun;90(3):190-9
pubmed: 24434034

Auteurs

Seray Karagöz Özdemir (SK)

1School of Medicine, Department of Internal Medicine, Akdeniz University, Antalya, Turkey.

Utku Iltar (U)

2Department of Hematology, Antalya Training and Research Hospital, Antalya, Turkey.

Ozan Salim (O)

3School of Medicine, Department of Internal Medicine, Department of Hematology, Akdeniz University, Antalya, Turkey.

Orhan Kemal Yücel (OK)

3School of Medicine, Department of Internal Medicine, Department of Hematology, Akdeniz University, Antalya, Turkey.

Ramazan Erdem (R)

3School of Medicine, Department of Internal Medicine, Department of Hematology, Akdeniz University, Antalya, Turkey.

Özge Turhan (Ö)

4School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Akdeniz University, Antalya, Turkey.

Levent Undar (L)

3School of Medicine, Department of Internal Medicine, Department of Hematology, Akdeniz University, Antalya, Turkey.

Classifications MeSH